Advertisement
Screener

The Procter & Gamble Company (PG) Cash and securities

The Procter & Gamble Company (PG) Cash and securities

  • Total cash · latest quarter (USD): Value $9.30B; Formula and calculation Cash and cash equivalents plus current marketable securities. Period ending 2019-09-30..
  • Cash per share · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities / reported quarter-end common shares. Period ending 2019-09-30..

Cash and securities

Overview →

Financial period ending 2019-09-30; current quote (m). Amounts retain their stated periods and units.

MetricValueFormula and calculation
Total cash · latest quarter (USD)$9.30BCash and cash equivalents plus current marketable securities. Period ending 2019-09-30.

$9.30B + $0.00 ≈ $9.30B

Cash per share · latest quarter(m)Cash and cash equivalents plus current marketable securities / reported quarter-end common shares. Period ending 2019-09-30.

Calculation unavailable: missing inputs remain (m).

Calculation inputs

InputAmount with unitRaw financial data
Cash and equivalents9.30B USDCash and Cash Equivalents, at Carrying Value
Short-term securities0.00 USDAvailable-for-sale Securities, Current
Cash and current securities9.30B USDCash and Cash Equivalents, at Carrying Value · Available-for-sale Securities, Current
Quarter-end shares(m)

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period endingTotal cashCash per shareCash and equivalents (USD)Short-term securities (USD)Quarter-end shares (shares)
2019-09-30$9.30B(m)$9.30B$0.00(m)
2019-06-30(m)(m)$4.24B(m)(m)
2019-03-31$9.82B(m)$2.74B$7.08B(m)
2018-12-31$12.12B(m)$3.70B$8.42B(m)
2018-09-30$11.25B(m)$2.54B$8.71B(m)
2018-06-30(m)(m)$2.57B(m)(m)
2018-03-31$15.53B(m)$5.33B$10.21B(m)
2017-12-31$18.76B(m)$7.43B$11.33B(m)
2017-09-30$16.01B(m)$5.02B$10.98B(m)
2017-06-30(m)(m)$5.57B(m)(m)
2017-03-31$14.33B(m)$5.82B$8.51B(m)
2016-12-31$13.45B(m)$6.05B$7.40B(m)
2016-09-30$14.07B(m)$7.46B$6.62B(m)
2016-06-30(m)(m)$7.10B(m)(m)
2016-03-31$13.82B(m)$7.89B$5.92B(m)
2015-12-31$14.28B(m)$9.40B$4.87B(m)
2015-09-30$12.61B(m)$7.71B$4.90B(m)
2015-06-30(m)(m)$6.84B(m)(m)
2015-03-31$13.16B(m)$8.37B$4.79B(m)
2014-12-31$12.25B(m)$8.20B$4.05B(m)
2014-09-30$10.85B(m)$7.49B$3.36B(m)
2014-06-30(m)(m)$8.56B(m)(m)
2014-03-31$9.75B(m)$8.18B$1.57B(m)
2013-12-31$8.50B(m)$6.93B$1.57B(m)
2013-09-30$7.70B(m)$6.12B$1.58B(m)
2013-06-30(m)(m)$5.95B(m)(m)
2013-03-31(m)(m)$5.88B(m)(m)
2012-12-31(m)(m)$6.64B(m)(m)
2012-09-30(m)(m)$5.30B(m)(m)
2012-06-30(m)(m)$4.44B(m)(m)
2012-03-31(m)(m)$3.99B(m)(m)
2011-12-31(m)(m)$4.41B(m)(m)
2011-09-30(m)(m)$3.58B(m)(m)
2011-06-30(m)(m)$2.77B(m)(m)
2011-03-31(m)(m)$2.95B(m)(m)
2010-12-31(m)(m)$3.25B(m)(m)
2010-09-30(m)(m)$2.60B(m)(m)
2010-06-30(m)(m)$2.88B(m)(m)
2010-03-31(m)(m)$4.90B(m)(m)
2009-12-31(m)(m)$4.13B(m)(m)
2009-09-30(m)(m)$6.29B(m)(m)
2009-06-30(m)(m)$4.78B(m)(m)
2009-03-31(m)(m)$4.43B(m)(m)
2008-12-31(m)(m)$5.65B(m)(m)
2008-09-30(m)(m)$4.50B(m)(m)
2008-06-30(m)(m)$3.31B(m)(m)
2007-06-30(m)(m)$5.35B(m)(m)
2006-06-30(m)(m)$6.69B(m)(m)

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.

Similar stocks

Stock NameCountryMarket CapPE Ratio
ECOLAB INC. (ECL)United States$77.183B36.58
CHURCH & DWIGHT CO INC /DE/ (CHD)United States$22.622B30.81
STEPAN CO (SCL)United States$1.451B-477.05
Longevity Health Holdings, Inc. (XAGE)United States$0.006B-0.09